More about

Nausea

News
April 24, 2025
5 min read
Save

Q&A: Spring has sprung — and so has prevalence of alpha-gal, other tick-borne illnesses

With spring underway, the likelihood of getting a tick-borne illness is elevated, according to Mayo Clinic. One that clinicians should be on the watch for is alpha-gal syndrome, a food allergy contracted mainly from Lone Star ticks.

News
April 04, 2025
1 min read
Save

Use of GLP-1 agonists prior to THA may increase postoperative nausea, vomiting

SAN DIEGO — GLP-1 agonists may lead to increased nausea and vomiting in the early postoperative period after total hip arthroplasty, according to results presented here.

News
April 02, 2025
4 min read
Save

Toxicity in phase 3 cancer trials often unreported, minimized

Toxicity information from phase 3 oncology clinical trials often is incomplete and interpreted in ways that minimize its impact, according to findings published in JCO Oncology Practice.

News
March 05, 2025
4 min read
Save

Q&A: ‘A lot of opportunity’ exists to educate patients on hemodialysis about cannabis use

Patients with kidney disease may be using cannabis recreationally or to treat symptoms without the knowledge of their health care team, according to results of a small survey of patients from a hemodialysis clinic in Canada.

News
October 18, 2024
1 min read
Save

FDA approves Vyloy with chemotherapy for some gastric cancers, approves diagnostic device

The FDA approved Vyloy with chemotherapy to treat locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma in adults, according to a press release.

News
September 27, 2024
2 min read
Save

Olanzapine improves nausea, quality of life more effectively than prochlorperazine

Olanzapine reduced severe nausea more effectively than prochlorperazine for patients with refractory symptoms after chemotherapy, according to results of a randomized phase 3 trial.

News
September 19, 2024
1 min read
Save

Vanda’s tradipitant falls short for gastroparesis as FDA requests ‘additional studies’

The FDA has issued a complete response letter to Vanda Pharmaceuticals indicating it cannot approve the company’s new drug application seeking approval for tradipitant as a treatment for gastroparesis.

News
September 17, 2024
3 min read
Save

New oral obesity drug safe, linked to weight loss in first-in-human study

In a first-in-human study, a novel oral amylin and GLP-1 receptor coagonist was safe and tolerable and lowered weight compared with placebo at 12 weeks in patients with obesity, researchers reported.

News
September 16, 2024
3 min read
Save

Mazdutide superior to dulaglutide for reducing HbA1c, body weight in type 2 diabetes

A once-weekly GLP-1/glucagon dual agonist conferred greater decreases in HbA1c and body weight than the GLP-1 receptor agonist dulaglutide for adults with type 2 diabetes, according to a presenter.

News
September 12, 2024
2 min read
Save

Black patients less likely to receive diagnostic testing for common conditions

White patients discharged from the ED with a nonspecific diagnosis, like vomiting or chest pain, were more likely to receive related diagnostic testing vs. Black patients, according to a recent analysis in JAMA Network Open.

View more